Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $107,168
AQST•CEO sells shares in August transaction
- Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on Aug. 17, 2026.
- Sale priced at a weighted average of $4.29 per share.
- Post-transaction holding reported at 585,574 shares.
